Virulence-associated protein A from Rhodococcus equi is an intercompartmental pH-neutralising virulence factor

Kristine von Bargen1, Mirella Scraba1, Ina Krämer1

  • 1Division of Biophysics, Cell Biology Institute, University of Bonn, Bonn, Germany.

Cellular Microbiology
|September 26, 2018
PubMed

Insights

The virulence-associated protein A (VapA) from Rhodococcus equi neutralizes phagosome acidity, creating a growth-promoting environment within macrophages. This novel Gram-positive virulence factor disarms host defenses by altering vacuole permeability and excluding proton pumps.

Area of Science:

  • Microbiology
  • Immunology
  • Cell Biology

Background:

  • Macrophages are key to innate immunity, engulfing pathogens in phagosomes that normally acidify.
  • Gram-positive Rhodococcus equi causes disease in foals and immunocompromised humans by subverting macrophage defenses.
  • Virulence plasmid-encoded factors enable R. equi to survive and multiply within host cells.

Purpose of the Study:

  • To investigate the role of virulence-associated protein A (VapA) in R. equi pathogenesis.
  • To elucidate the mechanism by which VapA allows R. equi to multiply within macrophages.
  • To characterize VapA's effect on phagosome and lysosome properties.

Main Methods:

  • Fluorescence and electron microscopy to track VapA localization.
  • Experiments with artificial lipid bilayers to study membrane permeabilization.
  • pH measurements of phagosomes containing wild-type, mutant, and plasmid-less R. equi strains.
  • Macrophage culture and infection assays.

Main Results:

  • VapA excludes the proton-pumping vacuolar-ATPase from phagosomes, leading to a neutral pH (7.2) compared to acidic phagosomes (pH 5.8-5.2) with mutants.
  • VapA is transferred to lysosomes, permeabilizing their membranes to protons.
  • Neutralizing macrophage endocytic system pH allows even avirulent R. equi to multiply.
  • Virulent and avirulent R. equi strains multiply in purified lysosomes at neutral pH but not acidic pH.

Conclusions:

  • VapA's primary function is to create a neutral, growth-promoting intracellular niche for R. equi.
  • VapA acts as a novel Gram-positive virulence factor by manipulating vacuolar compartments and host defenses.
  • Understanding VapA's mechanism offers insights into bacterial pathogenesis and potential therapeutic targets.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
565
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
486
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
327
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
605
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.0K